SkinStim News
Leonhardt’s Launchpads Announces Filing of Pioneering Patent for Bioelectric COL17A1 Protein Expression for Skin and Hair Regeneration
Also may be useful for other collagen and stem cell therapy applications Irvine, CA and Salt Lake City, UT - May 22nd, 2020 - Leonhardt's Launchpads innovation and startup launch accelerator, focused on bioelectric and biologics based organ regeneration and healing,...
Leonhardt Ventures and Axolotl Biologix Announce Partnership to Study Combination Bioelectric and Biologic Therapies
Published May 19, 2018 | By Api Podder Partnership aims to build on synergies of bioelectric stimulation + amniotic fluid based regenerative fluids + re-fillable micro infusion pumps + mixed stem cell based compositions for candidate therapies to be studied for organ...
Leonhardt Adds HIF-1 Alpha To Estate of Bioelectric Controlled Release Regenerative Proteins
Press Release – Salt Lake City, Utah and Santa Monica, CA – June 8th, 2017 (PRBUZZ) — Leonhardt’s Launchpads, an organ regeneration and recovery focused innovation/startup accelerator today announced that it has filed a new patent application claim for the controlled...
BioLeonhardt Files Provisional Patent Application For Electrical Stimulation Controlled Release Of Follistatin
Published: Feb 18, 2016 Santa Monica, CA and Salt Lake City, Utah , Feb. 16th, 2015 /PRBuzz- BioLeonhardt MyoStimwww.bioleonhardt.com funded by Leonhardt Ventures a developer, manufacturer and marketer of advanced organ regeneration products focused on the heart and...
Leonhardt And Genovese File Patent For Bioelectric Controlled Expression Of PDGF A Powerful Organ Regeneration Cytokine
Published: Dec 20, 2016 Salt Lake City, Utah and Los Angeles, CA - December 19, 2016 (PRBUZZ) -- Leonhardt's Launchpads, an organ regeneration focused innovation/startup accelerator, focused on developing novel therapeutics for the treatment of organ degeneration...